Trends and comparison of skin and subcutaneous diseases burden in the United States and globally: An update from the Global Burden of Disease Study 2021

Fig 1. Map of age-standardized DALYs rates for total skin and subcutaneous diseases in the US in 1990
Fig 2. Map of age-standardized DALYs rates for malignant skin melanoma in the US in 1990
Fig 3. Maps of age-standardized prevalence rates for total skin and subcutaneous diseases and malignant skin melanoma in the US in 1990 and 2021
Fig 4. Maps of age-standardized incidence rates for total skin and subcutaneous diseases and malignant skin melanoma in the US in 1990 and 2021
Fig 5. Maps of age-standardized prevalence rates for skin and subcutaneous diseases and non-melanoma skin cancer in the US in 1990
Fig 6. Maps of age-standardized prevalence rates for skin and subcutaneous diseases and non-melanoma skin cancer in the US in 2021.
Fig 7. Maps of age-standardized incidence rates for skin and subcutaneous diseases and non-melanoma skin cancer in the US in 1990
Fig 8. Maps of age-standardized incidence rates for skin and subcutaneous diseases and non-melanoma skin cancer in the US in 2021
Fig 9. Maps of age-standardized DALYs rates for skin and subcutaneous diseases and non-melanoma skin cancer in the United States in 1990
Fig 10. Maps of age-standardized DALYs rates for skin and subcutaneous diseases and non-melanoma skin cancer in the US in 2021
Fig 11. Heatmap of the age-standardized prevalence rates for skin and subcutaneous diseases and skin cancers globally and across US States in 1990
Fig 12. Heatmap of the age-standardized prevalence rates for skin and subcutaneous diseases and skin cancers globally and across US States in 2021
Fig 13. Heatmap of the age-standardized incidence rates for skin and subcutaneous diseases and skin cancers globally and across US States in 1990
Fig 14. Heatmap of the age-standardized incidence rates for skin and subcutaneous diseases and skin cancers globally and across US States in 2021
Fig 15. Heatmap of the age-standardized DALYs rates of skin and subcutaneous diseases and skin cancers globally and across US States in 1990
Fig 16. Comparison of DALYs burden for total skin and subcutaneous diseases by gender and age cohort globally in 2021
Fig 17. Comparison of prevalence and incidence burden for total skin and subcutaneous diseases by gender and age cohort in the US in 2021
Fig 18. Comparison of DALYs burden for malignant skin melanoma by gender and age cohort in the US in 2021
Fig 19. Comparison of prevalence and incidence burden for malignant skin melanoma by gender and age cohort in the US in 2021
Fig 20. Comparison of burden for non-melanoma skin cancer by gender and age cohort globally and in the US in 2021
Table 1. Burden and changes for total skin and subcutaneous diseases globally and across US States, 1990-2021
Table 2. Burden and changes for skin and subcutaneous diseases and non-melanoma skin cancer globally and in the US based on gender stratification, 1990-2021
Table 3. Burden and changes for malignant skin melanoma globally and across US States, 1990-2021